: Bionomics’ stock rallies 103% after company reports positive results in trial of PTSD treatment

The stock of microcap Bionomics Ltd. rose 103% early Thursday, after the company reported positive results from a mid-stage trial of a treatment for PTSD.

Previous post : GameStop stock soars after Ryan Cohen named CEO
Next post Bond Report: Ten-year Treasury yields at fresh 16-year highs amid oil price surge